Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Electromagnetic Field Therapy on Improving Quality of Life and Gait Performance in Patients With Type 2 Diabetes Mellitus and Peripheral Arterial Disease. Randomized Controlled Trial

NCT07864805 is registered in ClinicalTrials.gov with Ashraf Abdelaal as lead sponsor.

NCT NCT07864805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07864805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Electromagnetic Field Therapy on Improving Quality of Life and Gait Performance in Patients With Type 2 Diabetes Mellitus and Peripheral Arterial Disease. Randomized Controlled Trial
Lead sponsor
Ashraf Abdelaal
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2025
Completion date
May 28, 2026
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabete type 2, gait abnormality, peripheral arterial disease (pad), quality of life